FREE SHIPPING ON ORDERS OVER $150

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Nitrogen monoxide (NO)-mediated iron release

$21.98

Quantity
- +
Description

Wiley CD, Campisi J

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Nitrogen monoxide (NO)-mediated iron release

Curcumin: synthesis optimization and in silico interaction with cyclin dependent kinase

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Nitrogen monoxide (NO)-mediated iron release

ERs also regulate pathways such as mTOR and HK2

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Nitrogen monoxide (NO)-mediated iron release

A derivative of clinically proven, superstar ingredient Azelaic Acid and hydrating amino acid Glycine

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Nitrogen monoxide (NO)-mediated iron release

10.1016/j.it.2007.03.003 [DOI] [PubMed] [Google Scholar] Miguel M

mk571 mrp1 glutathione efflux modulators synergize with buthionine sulfoximine to exploit collateral sensitivity and selectively kill MRP1-expressing cancer cells Nitrogen monoxide (NO)-mediated iron release

You may also like

recommand products